BioCentury This Week cover image

Ep. 104 - Biotech Shows Support for Ukraine, Plus Latest Intellia Data

BioCentury This Week

00:00

Biotexs

There are a couple other new modalities on the market. It's more effective. And crisper cas onis potentially a one time treatment, which is the biggest difference for patients who would have to be treated with an s i r an a or an r an a i, relatively frequently every couple months. Here's hoping it's good for the sector. A, it's been a pretty dreary past 52 weeks. Any thoughts on that? Loren, well, their share price has risen about 20 % over the last five days leading up to this announcement. So investors were optimistic about the data. Of course, crisper and editas are also stocks to watch.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app